ClinicalTrials.gov
ClinicalTrials.gov Menu

BI836826 Dose Escalation in Relapsed Chronic Lymphocytic Leukaemia (CLL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01296932
Recruitment Status : Completed
First Posted : February 16, 2011
Last Update Posted : August 17, 2017
Sponsor:
Information provided by (Responsible Party):
Boehringer Ingelheim

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 30, 2017
  Actual Study Completion Date : May 30, 2017